BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7523429)

  • 41. Cerebrovascular responses to subarachnoid blood and serotonin in the monkey.
    Boisvert DP; Weir BK; Overton TR; Reiffenstein R; Grace MG
    Acta Neurol Scand Suppl; 1977; 64():322-3. PubMed ID: 409069
    [No Abstract]   [Full Text] [Related]  

  • 42. Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer's disease: A nationwide population-based cohort study.
    Lee HW; Kim S; Jo Y; Kim Y; Ye BS; Yu YM
    Front Aging Neurosci; 2023; 15():1137197. PubMed ID: 36949774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroinflammation in Parkinson's Disease - Putative Pathomechanisms and Targets for Disease-Modification.
    Grotemeyer A; McFleder RL; Wu J; Wischhusen J; Ip CW
    Front Immunol; 2022; 13():878771. PubMed ID: 35663989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets.
    Royea J; Hamel E
    Geroscience; 2020 Oct; 42(5):1237-1256. PubMed ID: 32700176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of brain renin angiotensin system in neurodegeneration: An update.
    Abiodun OA; Ola MS
    Saudi J Biol Sci; 2020 Mar; 27(3):905-912. PubMed ID: 32127770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.
    Hamel E; Royea J; Ongali B; Tong XK
    Cell Mol Neurobiol; 2016 Mar; 36(2):219-32. PubMed ID: 26993506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multimodal MRI characterization of experimental subarachnoid hemorrhage.
    Sun Y; Shen Q; Watts LT; Muir ER; Huang S; Yang GY; Suarez JI; Duong TQ
    Neuroscience; 2016 Mar; 316():53-62. PubMed ID: 26708744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].
    Karnik SS; Unal H; Kemp JR; Tirupula KC; Eguchi S; Vanderheyden PM; Thomas WG
    Pharmacol Rev; 2015 Oct; 67(4):754-819. PubMed ID: 26315714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases.
    Wright JW; Kawas LH; Harding JW
    Front Endocrinol (Lausanne); 2013 Oct; 4():158. PubMed ID: 24298267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Importance of the brain Angiotensin system in Parkinson's disease.
    Wright JW; Harding JW
    Parkinsons Dis; 2012; 2012():860923. PubMed ID: 23213621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.
    Wright JW; Harding JW
    Pflugers Arch; 2013 Jan; 465(1):133-51. PubMed ID: 22535332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renin-angiotensin system blockers and modulation of radiation-induced brain injury.
    Robbins ME; Zhao W; Garcia-Espinosa MA; Diz DI
    Curr Drug Targets; 2010 Nov; 11(11):1413-22. PubMed ID: 20583976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy.
    De Bundel D; Smolders I; Vanderheyden P; Michotte Y
    CNS Neurosci Ther; 2008; 14(4):315-39. PubMed ID: 19040556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.
    Wright JW; Yamamoto BJ; Harding JW
    Prog Neurobiol; 2008 Feb; 84(2):157-81. PubMed ID: 18160199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin and cerebral blood flow.
    Saavedra JM; Nishimura Y
    Cell Mol Neurobiol; 1999 Oct; 19(5):553-73. PubMed ID: 10384255
    [No Abstract]   [Full Text] [Related]  

  • 56. Angiotensin IV reverses the acute cerebral blood flow reduction after experimental subarachnoid hemorrhage in the rat.
    Näveri L; Strömberg C; Saavedra JM
    J Cereb Blood Flow Metab; 1994 Nov; 14(6):1096-9. PubMed ID: 7523429
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of angiotensin receptor subtypes in cerebrovascular regulation in the rat.
    Näveri L
    Acta Physiol Scand Suppl; 1995; 630():1-48. PubMed ID: 8610501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebral blood flow changes during cortical spreading depression are not altered by inhibition of nitric oxide synthesis.
    Zhang ZG; Chopp M; Maynard KI; Moskowitz MA
    J Cereb Blood Flow Metab; 1994 Nov; 14(6):939-43. PubMed ID: 7523432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS; Clark KL; Johns EJ; Drew GM
    Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nitric oxide synthase is critical in mediating basal forebrain regulation of cortical cerebral circulation.
    Raszkiewicz JL; Linville DG; Kerwin JF; Wagenaar F; Arneric SP
    J Neurosci Res; 1992 Sep; 33(1):129-35. PubMed ID: 1280688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.